Literature DB >> 23115281

The viral interferon regulatory factors of kaposi's sarcoma-associated herpesvirus differ in their inhibition of interferon activation mediated by toll-like receptor 3.

Sarah R Jacobs1, Sean M Gregory, John A West, Amy C Wollish, Christopher L Bennett, David J Blackbourn, Mark T Heise, Blossom Damania.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) infection is correlated with three human malignancies and can establish lifelong latent infection in multiple cell types within its human host. In order to establish and maintain infection, KSHV utilizes multiple mechanisms to evade the host immune response. One such mechanism is the expression of a family of genes with homology to cellular interferon (IFN) regulatory factors (IRFs), known as viral IRFs (vIRFs). We demonstrate here that KSHV vIRF1, -2, and -3 have a differential ability to block type I interferon signaling mediated by Toll-like receptor 3 (TLR3), a receptor we have previously shown to be activated upon KSHV infection. vIRF1, -2, and -3 inhibited TLR3-driven activation of IFN transcription reporters. However, only vIRF1 and vIRF2 inhibited increases in both IFN-β message and protein levels following TLR3 activation. The expression of vIRF1 and vIRF2 also allowed for increased replication of a virus known to activate TLR3 signaling. Furthermore, vIRF1 and vIRF2 may block TLR3-mediated signaling via different mechanisms. Altogether, this report indicates that vIRFs are able to block IFN mediated by TLRs but that each vIRF has a unique function and mechanism for blocking antiviral IFN responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23115281      PMCID: PMC3554052          DOI: 10.1128/JVI.01851-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis.

Authors:  T Seo; J Park; D Lee; S G Hwang; J Choe
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

3.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling.

Authors:  Katharina Heinzelmann; Barbara A Scholz; Agnes Nowak; Even Fossum; Elisabeth Kremmer; Juergen Haas; Ronald Frank; Bettina Kempkes
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

4.  Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.

Authors:  Yan-Jin Zhang; Deendayal Patel; Yuchen Nan; Sumin Fan
Journal:  Antivir Ther       Date:  2011

5.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Viral interferon regulatory factors decrease the induction of type I and type II interferon during rhesus macaque rhadinovirus infection.

Authors:  Bridget A Robinson; Ryan D Estep; Ilhem Messaoudi; Kelsey S Rogers; Scott W Wong
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

7.  Activation of the interferon-beta promoter during hepatitis C virus RNA replication.

Authors:  Brenda Fredericksen; Giridhar R Akkaraju; Eileen Foy; Chunfu Wang; Jill Pflugheber; Zhijian J Chen; Michael Gale
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

8.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3.

Authors:  M Mutocheluh; L Hindle; C Aresté; S A Chanas; L M Butler; K Lowry; K Shah; D J Evans; D J Blackbourn
Journal:  J Gen Virol       Date:  2011-06-22       Impact factor: 3.891

9.  Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.

Authors:  Taegun Seo; Daeyoup Lee; Young Sam Shim; Jon E Angell; Natesa V Chidambaram; Dhananjaya V Kalvakolanu; Joonho Choe
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation.

Authors:  M Esteban; M A García; E Domingo-Gil; J Arroyo; C Nombela; C Rivas
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

View more
  34 in total

1.  Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 Interacts with a Member of the Interferon-Stimulated Gene 15 Pathway.

Authors:  Sarah R Jacobs; Charles M Stopford; John A West; Christopher L Bennett; Louise Giffin; Blossom Damania
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

2.  KSHV-encoded viral interferon regulatory factor 4 (vIRF4) interacts with IRF7 and inhibits interferon alpha production.

Authors:  Sung-Woo Hwang; DongIk Kim; Jae U Jung; Hye-Ra Lee
Journal:  Biochem Biophys Res Commun       Date:  2017-03-22       Impact factor: 3.575

Review 3.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

4.  Caspase-Dependent Suppression of Type I Interferon Signaling Promotes Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.

Authors:  Tate Tabtieng; Alexei Degterev; Marta M Gaglia
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

5.  Comparative analysis of the viral interferon regulatory factors of KSHV for their requisite for virus production and inhibition of the type I interferon pathway.

Authors:  Gavin Golas; Seung Jin Jang; Nenavath Gopal Naik; Juan D Alonso; Bernadett Papp; Zsolt Toth
Journal:  Virology       Date:  2019-12-30       Impact factor: 3.616

6.  Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome.

Authors:  A Jamin; L Dehoux; C Dossier; M Fila; N Heming; R C Monteiro; G Deschênes
Journal:  Clin Exp Immunol       Date:  2015-09-30       Impact factor: 4.330

7.  Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.

Authors:  Meilan He; Fan Cheng; Suzane Ramos da Silva; Brandon Tan; Océane Sorel; Marion Gruffaz; Tingting Li; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2019

Review 8.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

Review 9.  Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.

Authors:  Kevin Brulois; Jae U Jung
Journal:  Cytokine Growth Factor Rev       Date:  2014-06-21       Impact factor: 7.638

10.  The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response.

Authors:  Kendra A Bussey; Elisa Reimer; Helene Todt; Brigitte Denker; Antonio Gallo; Andreas Konrad; Matthias Ottinger; Heiko Adler; Michael Stürzl; Wolfram Brune; Melanie M Brinkmann
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.